Metronidazole Market Forecast to 2032: Highlights Trends and the Competitive Landscape in CDI Treatment
30 janv. 2024 06h44 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Metronidazole Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This insightful report provides...
Vancomycin Drug Insights and Market Forecast to 2032 for Clostridium Difficile Infection Treatment in Key Global Regions
29 janv. 2024 12h38 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Vancomycin Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report presents an in-depth...
Global Glycopeptide Antibiotics Market to Surge from $3.05 Billion in 2022 to $3.29 Billion in 2023, Driven by a 7.7% CAGR, Reaching $4.43 Billion by 2027
24 oct. 2023 04h03 HE
|
Research and Markets
Dublin, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The "Glycopeptide Antibiotics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global glycopeptide antibiotics...
Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Global Market Research Report 2023
11 sept. 2023 06h48 HE
|
Research and Markets
Dublin, Sept. 11, 2023 (GLOBE NEWSWIRE) -- The "Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The...
Vancomycin Market Size, Share [2022] | is Projected to Reach at a CAGR of 10.65% | Industry Demand, Growth Rate, Type & Applications, Revenue, Key Players | Market Status and Forecast Research | Business Research Insights
11 avr. 2022 04h09 HE
|
Business Research Insights
Pune, April 11, 2022 (GLOBE NEWSWIRE) -- Global Vancomycin Market [2022] research report represents a detailed overview of the current market situation and forecast till 2025. The study is perhaps a...
Tabula Rasa HealthCare’s DoseMeRx™ Integrates with The Sanford Guide
21 avr. 2020 08h00 HE
|
Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J., April 21, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc® (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, and Antimicrobial...
VigiLanz® Announces Precision Dosing Powered by Tabula Rasa HealthCare’s DoseMeRx™
02 avr. 2020 08h00 HE
|
Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J., April 02, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc® (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, has partnered with...
Global Clostridium Difficile Diagnostics and Treatment Market to Surpass US$ 2,576.3 Million by 2025
05 avr. 2018 10h00 HE
|
Coherent Market Insights
SEATTLE, April 05, 2018 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global clostridium difficile diagnostics and treatment market was valued at US$ 1,376.0 million in 2017 and is...